tm logo

Monitor this mark

View On USPTO

TAZTIA XT
Live/Registered
REGISTERED AND RENEWED

on 13 Oct 2023

Last Applicant/ Owned by

ACTAVIS HOLDCO US, INC.

400 INTERPACE PARKWAY

PARSIPPANY

NJ

07054

Serial Number

85118870 filed on 30th Aug 2010

Registration Number

4263084 registered on 25th Dec 2012

in the Principal Register

Correspondent Address

Laurence Rickles

Laurence Rickles

400 Interpace Parkway

Parsippany NJ 07054

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

TAZTIA XT

Pharmaceutical product for the treatment of Angina and Hypertension

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical product for the treatment of Angina and Hypertension

First Use Date in General

10th Apr 2003

First Use Date in Commerce

10th Apr 2003

Specimens

TAZTIA XT specimenTAZTIA XT specimenTAZTIA XT specimen

Mark Details

Serial Number

No 85118870

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
13th Oct 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Oct 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13th Oct 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
13th Oct 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12th Apr 2023TEAS SECTION 8 & 9 RECEIVED
25th Dec 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
24th Nov 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24th Nov 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24th Nov 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02th Nov 2018TEAS SECTION 8 & 15 RECEIVED